Full screen

Share

International partners
Halifax

Ottawa
Edmonton
Montreal
Vancouver

Winnipeg
Calgary
Want to make interactive content? It’s easy in Genially!

Over 30 million people build interactive content in Genially.

Check out what others have designed:

Transcript

Calgary

Winnipeg

Vancouver

Montreal

Edmonton

Ottawa

Halifax

International partners

Dr. Karthik Tennankore MD, SM, FRCPCResearcher, Halifax SITE LEADDr. Karthik Tennankore received his MD at the University of Western Ontario, and completed Internal Medicine and Nephrology at Dalhousie University. He went on to complete a two year clinical fellowship in home dialysis at the Toronto General Hospital (University of Toronto), and concurrently obtained a Master of Science in Clinical Epidemiology through Harvard University.He joined the Dalhousie Division of Nephrology in 2013. His clinical expertise is primarily in the area of home dialysis and he is the medical lead of home therapies for the Nova Scotia Central Zone Renal Program. From the perspective of research, he is the current research lead for the Dalhousie Division of Nephrology (Department of Medicine). He is interested in studying and improving outcomes of patients after initiation of home and in-center dialysis and transplantation, and in studying the effect of frailty on dialysis and transplant patient outcomes. He is involved in clinical trials and conducts a number of prospective cohort studies in nephrology.

Dr. Karthik Tennankore MD, SM, FRCPCResearcher, Halifax Dr. Karthik Tennankore received his MD at the University of Western Ontario, and completed Internal Medicine and Nephrology at Dalhousie University. He went on to complete a two year clinical fellowship in home dialysis at the Toronto General Hospital (University of Toronto), and concurrently obtained a Master of Science in Clinical Epidemiology through Harvard University. He joined the Dalhousie Division of Nephrology in 2013. His clinical expertise is primarily in the area of home dialysis and he is the medical lead of home therapies for the Nova Scotia Central Zone Renal Program. From the perspective of research, he is the current research lead for the Dalhousie Division of Nephrology (Department of Medicine). He is interested in studying and improving outcomes of patients after initiation of home and in-center dialysis and transplantation, and in studying the effect of frailty on dialysis and transplant patient outcomes. He is involved in clinical trials and conducts a number of prospective cohort studies in nephrology.

Dr. Karthik Tennankore MD, SM, FRCPCResearcher, Halifax Dr. Karthik Tennankore received his MD at the University of Western Ontario, and completed Internal Medicine and Nephrology at Dalhousie University. He went on to complete a two year clinical fellowship in home dialysis at the Toronto General Hospital (University of Toronto), and concurrently obtained a Master of Science in Clinical Epidemiology through Harvard University. He joined the Dalhousie Division of Nephrology in 2013. His clinical expertise is primarily in the area of home dialysis and he is the medical lead of home therapies for the Nova Scotia Central Zone Renal Program. From the perspective of research, he is the current research lead for the Dalhousie Division of Nephrology (Department of Medicine). He is interested in studying and improving outcomes of patients after initiation of home and in-center dialysis and transplantation, and in studying the effect of frailty on dialysis and transplant patient outcomes. He is involved in clinical trials and conducts a number of prospective cohort studies in nephrology.

Dr. clara bohmPrincipAL investigator, winnipeg SITE LEAD Dr. Clara Bohm is an Assistant Professor at the University of Manitoba and a Nephrologist in the Manitoba Renal Program. She completed her MD at McMaster University and went on to complete her Internal Medicine residency at the University of Saskatchewan and Nephrology training at Dalhousie University. She subsequently completed a Master’s in Public Health at Johns Hopkins School of Public Health in 2014. Her overall research interest focuses on improving quality of life in people with all stages of chronic kidney disease. In addition to identifying challenges and solutions to better patient-centred care in hemodialysis through the Triple I Study, her other main area of interest involves characterizing the effect of exercise on symptom burden, frailty, functional status and other outcomes in hemodialysis. Dr. Bohm feels privileged to be working with such a talented and enthusiastic team for the Triple I project and is excited about the project’s excellent progress and what we will able to accomplish. RACHELLE SASS RESEARCH COORDINATOR Rachelle Sass is a Research Coordinator at the Chronic Disease Innovation Centre at Seven Oaks General Hospital in Winnipeg. She completed her Master of Arts degree in Psychology from York University, Toronto in 2015. Thereafter, she worked in Germany for three years researching and teaching at several universities where she specialized in Health Psychology. Her primary research involvement at the CDIC is the Triple I project, where she eagerly anticipates working with the team to implement solutions across Canada in order to provide hemodialysis patients with the best possible care. In addition, her work on targeted deprescribing in hemodialysis patients aims to decrease their usage of unnecessary pharmaceutical medications, which may ultimately improve their quality of life. PRISCILA FERREIRA DA SILVA Priscila Ferreira da Silva holds a BA (Hons) in Indigenous Studies from the University of Saskatchewan and is currently pursuing a Masters in Community Health Sciences at the University of Manitoba. Priscila’s involvement with Triple I has led her to conduct an ethnographic study for a master's thesis to identify the constellation of barriers and facilitators particularly influencing the wellbeing and quality of life of Indigenous patients on hemodialysis in Winnipeg, Manitoba. This proposed study also seeks to understand how the structural barriers that Indigenous patients face are connected to a broader history of settler colonialism in Canada.

Dr. Manish M. Sood, MD, MS, FASN Researcher, ottawa SITE LEAD Dr. Sood is an Associate Professor of Medicine at theUniversityofOttawa with a cross appointment at the School of Epidemiology and Public Health, Associate Scientist at the Ottawa Hospital Research Institute and the Institute for Clinical Evaluative Sciences, Deputy Editor- in- Chief and founder of the Canadian Journal of Kidney Health and Disease, and holds the Jindal Research Chair for the Prevention of Kidney Disease. He completed his undergraduate (BSc) at Carleton and Lancaster University (UK) followed by medical school, internal medicine and nephrology residency training at the University of Toronto. He began his career as a clinical nephrologist at the St Boniface Hospital inWinnipeg,Manitoba, gradually developing an interest in research and clinical epidemiology and in 2013 became a clinician scientist. He completed his Masters in Science in Epidemiology at the University of Ottawa. More recently, he became the Associate Director of the Kidney, Dialysis, transplantation Program at the Institute for Clinical Evaluative Sciences, a Dialysis Outcomes and Practice Patterns (DOPPS) country investigator, and a member of the Canadian Organ Replacement Registry (CORR) Board of Directors.

Dr. Marcello tonelliCo-Principal Investigator, Calgary SITE LEAD Dr. Tonelli joined the University of Calgary in 2014, taking on the roles of Senior Associate Dean (Health Research) at the Cumming School of Medicine and Associate Vice President (Health Research). Dr. Tonelli’s research focuses on improving the care of people with chronic kidney disease and other noncommunicable diseases. He completed a volunteership at the World Health Organization in 2013-2014, focusing on treatment of noncommunicable diseases. During this time, he also completed an MSc in Health Policy from Imperial College London. He has published more than 450 peer-reviewed manuscripts and his H-index as calculated by Web of Science is 80. Dr. Tonelli is chair emeritus of the Canadian Task Force on Preventive Health Care, a past President of the Canadian Society of Nephrology, and leads the International Society of Nephrology’s global research portfolio. He was the recipient of the 2013 United States National Kidney Foundation Medal for Distinguished Service and the Kidney Foundation of Canada’s 2013 Medal for Research Excellence for changing nephrology practice in Canada and beyond. Dr. Tonelli was elected a fellow of the Canadian Academy of Health Sciences in 2012 and named a “Highly Cited” researcher in 2015, 2016 and 2017 by Thomson-Reuters, corresponding to a rank in the top 1% by citations of all researchers worldwide. Since 2005, Dr. Tonelli has been the co-leader of a joint initiative with the Hospital Civil de Guadalajara, aimed at prevention of kidney failure in poor communities of Jalisco, Mexico. Dr. MATTHEW JAMES Dr. James is a kidney doctor and specializes in health systems and services research. He uses multidisciplinary initiatives to implement and evaluate prevention strategies for disorders and to improve care for patients with kidney and cardiovascular disease. Working with stakeholders in medicine, Dr. James' work focuses on clinical implementation of decision support strategies, use of risk prediction models, and alerting systems in clinical electronic systems.

DR. CLAIRE HARRIS Dr. Claire Harris received her MD and completed Internal Medicine and Nephrology training at the University of British Columbia. After her Nephrology fellowship, she completed an extra year of training in Hemodialysis at UBC and a certificate in quality improvement at the University of Toronto. She recently completed a Masters in Health Administration, also at UBC. Her area of interest is quality improvement in the area of hemodialysis as well as clinical research in this area. She is a clinical nephrologist working at Vancouver General Hospital in Vancouver.

MONTREAL

DR. NEESH PANNU Dr. Neesh Pannu is the co-Scientific Director for the Kidney Health Strategic Clinical Network. She is a nephrologist and Professor in the Department of Medicine at the University of Alberta. She received her medical training at the University of Alberta, Stanford University and completed her SM in Epidemiology and Biostatistics at the Harvard University.Her research interests are primarily in the area of diagnosis, management, and outcomes of acute kidney injury. She is member of the Alberta Kidney Disease Network (AKDN) and the Interdisciplinary Chronic Disease Collaboration (ICDC). She also holdthe positionofassistant Dean of Clinical Research Platforms at the University of Alberta. DR. STEPHANIE THOMPSON Dr. Thompson is an Assistant Professor in the Division of Nephrology. She completed her clinical Nephrology training and her Internal Medicine training at the University of Alberta. She subsequently obtained a PhD in Epidemiology through the School of Public Health at the University of Alberta. She is the physician lead for the Northern Alberta Renal Program's Clinical Exercise Program. Clinical Practice Dr. Thompson has a general Nephrology out-patient practice and is one of the attending Nephrologists on the home and peritoneal dialysis units. She is also the attending Nephrologist for Grande Prairie and Peace River satellite dialysis units. Research Dr. Thompson’s research interests include trials that test lifestyle interventions in people with chronic kidney disease, with a focus on exercise and developing strategies on how to increase the adoption of exercise into the care of people with chronic kidney disease. She is also interested in examining how behavioural interventions and technology can be used to promote patient engagement in self-care. Dr. Thompson’s methodological interests include the design and conduct of clinical trials, qualitative research, and realist evaluation and synthesis in the evaluation of healthcare delivery. SUE SZIGETY Sue Szigety is a clinical study coordinator for the Kidney Health Research Group in the Division of Nephrology at the University of Alberta. Her education includes a Bachelor of Science degree from the University of Western Ontario, and a Master of Science degree from the University of Alberta. After many years in the field of cancer research, both in a clinical and non-clinical setting, Sue joined the nephrology team in 2007. Sue has 15 years of experience in clinical research. Helping investigators to find new ways to help improve the care and outcomes of patients with chronic diseases has been a rewarding career. Interacting with all of the amazing study participants has been even more rewarding! Sue is particularly interested in research that empowers patients to participate in their own care.

DR. ALLISON TONG Professor Allison Tong is a Principal Research Fellow with a Robinson Fellowship at the Sydney School of Public Health, The University of Sydney. She held an Australian National Health and Medical Research Council (NHMRC) Career Development Fellowship to 2019. She is a social scientist with experience in patient-centred outcomes research in chronic disease, particularly chronic kidney disease. Allison has an interest in patient involvement in research, including in the context of research priority setting, the development of core outcomes for research, and in the co-production of clinical trials. She co-founded and is on the Executive Committee of the global Standardised Outcomes in Nephrology (SONG) Initiative, which aims to establish consensus-based core outcomes across the spectrum of chronic kidney disease (www.songinitiative.org). She established the Patient-Centred Research Network (PACER, www.pacernetwork.org.au) network, which aims to facilitate knowledge exchange, cross-disciplinary collaboration, and innovation in conducting and implementing patient-centred outcomes research and patient involvement in research.

Show interactive elements